[HTML][HTML] Artificial intelligence to deep learning: machine intelligence approach for drug discovery

R Gupta, D Srivastava, M Sahu, S Tiwari, RK Ambasta… - Molecular …, 2021 - Springer
Drug designing and development is an important area of research for pharmaceutical
companies and chemical scientists. However, low efficacy, off-target delivery, time …

[HTML][HTML] De novo molecular design and generative models

J Meyers, B Fabian, N Brown - Drug discovery today, 2021 - Elsevier
Molecular design strategies are integral to therapeutic progress in drug discovery.
Computational approaches for de novo molecular design have been developed over the …

Artificial intelligence in drug discovery: recent advances and future perspectives

J Jiménez-Luna, F Grisoni, N Weskamp… - Expert opinion on drug …, 2021 - Taylor & Francis
Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The
widespread adoption of machine learning, in particular deep learning, in multiple scientific …

Generative deep learning for targeted compound design

T Sousa, J Correia, V Pereira… - Journal of Chemical …, 2021 - ACS Publications
In the past few years, de novo molecular design has increasingly been using generative
models from the emergent field of Deep Learning, proposing novel compounds that are …

[HTML][HTML] Comprehensive survey of recent drug discovery using deep learning

J Kim, S Park, D Min, W Kim - International Journal of Molecular Sciences, 2021 - mdpi.com
Drug discovery based on artificial intelligence has been in the spotlight recently as it
significantly reduces the time and cost required for developing novel drugs. With the …

Artificial intelligence to bring nanomedicine to life

N Serov, V Vinogradov - Advanced Drug Delivery Reviews, 2022 - Elsevier
The technology of drug delivery systems (DDSs) has demonstrated an outstanding
performance and effectiveness in production of pharmaceuticals, as it is proved by many …

Reinforced genetic algorithm for structure-based drug design

T Fu, W Gao, C Coley, J Sun - Advances in Neural …, 2022 - proceedings.neurips.cc
Abstract Structure-based drug design (SBDD) aims to discover drug candidates by finding
molecules (ligands) that bind tightly to a disease-related protein (targets), which is the …

[HTML][HTML] Artificial intelligence and machine learning based intervention in medical infrastructure: a review and future trends

K Kumar, P Kumar, D Deb, ML Unguresan, V Muresan - Healthcare, 2023 - mdpi.com
People in the life sciences who work with Artificial Intelligence (AI) and Machine Learning
(ML) are under increased pressure to develop algorithms faster than ever. The possibility of …

[HTML][HTML] Integrating structure-based approaches in generative molecular design

M Thomas, A Bender, C de Graaf - Current Opinion in Structural Biology, 2023 - Elsevier
Generative molecular design for drug discovery and development has seen a recent
resurgence promising to improve the efficiency of the design-make-test-analyse cycle; by …

[HTML][HTML] Past, present, and future perspectives on computer-aided drug design methodologies

D Bassani, S Moro - Molecules, 2023 - mdpi.com
The application of computational approaches in drug discovery has been consolidated in
the last decades. These families of techniques are usually grouped under the common …